Eisai
4523.T
#2008
Rank
C$13.43 B
Marketcap
C$47.67
Share price
-0.53%
Change (1 day)
13.76%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.24. In 2026 the company made an earnings per share (EPS) of C$1.24 a decrease over its 2025 EPS that were of C$1.57.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026C$1.24-21.04%
2025C$1.5711.85%
2024C$1.40-32.63%
2023C$2.085.52%
2022C$1.97-74.01%
2021C$7.58-66.58%
2020C$22.6898.24%
2019C$11.4417.01%
2018C$9.7837.78%
2017C$7.10-27.62%
2016C$9.8035.33%
2015C$7.24-2.82%
2014C$7.45-27.66%
2013C$10.30-27.49%
2012C$14.21-12.67%
2011C$16.2788.08%
2010C$8.65-11.06%
2009C$9.73-390.15%
2008C-$3.35-127.78%
2007C$12.07347.11%
2006C$2.704.38%
2005C$2.597.4%
2004C$2.4143.03%
2003C$1.6825.09%
2002C$1.3552.67%
2001C$0.8869.76%
2000C$0.52